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Background: Mental disorders such as depression, anxiety and suicide represent an important public health
problem in India. Elsewhere in the world a high prevalence of symptoms of common mental disorders have been
found among people who inject drugs (PWID). Research in India has largely overlooked symptoms of common
mental disorders among this high risk group. This paper reports on the results of a survey examining quality of life,
depression, anxiety and suicidal ideation among adult males who inject drugs living in Delhi.
Methods: Participants (n = 420) were recruited from needle and syringe programs using time location sampling
and were interviewed using an interviewer-administered questionnaire. Self-report symptom scales were used to
measure the severity of symptoms of depression (PHQ-9) and anxiety (GAD-2) within the preceding 2 weeks. We
assessed the presence of suicidal thoughts and attempts within the past 12 months.
Results: The mean length of injecting career was 20.9 years indicating a sample of chronic injecting drug users, of
whom only one-third (38%) were born in Delhi. The level of illiteracy was very high (62%), and just 2% had
completed class 12. Scavenging / rag picking was the main form of income for 48%, and many were homeless
(69%). One-third (33%) had been beaten up at least twice during the preceding 6 months, and many either never
(45%) or rarely (27%) attended family events. We found a high prevalence of depressive (84%, cut-off ≥10) and
anxiety (71%, cut-off score of ≥3) symptoms. Fifty-three percent thought about killing themselves in the past
12 months, and 36% had attempted to kill themselves.
Conclusions: Our findings revealed a socially excluded population of PWID in Delhi who have minimal education
and are often homeless, leaving them vulnerable to physical violence, poverty, poor health, imprisonment and
disconnection from family. The high prevalence of psychological distress found in this study has implications for
programmes seeking to engage, treat and rehabilitate PWID in India.Background
Mental disorders are one of the leading contributors to
the global burden of disease in both high and low in-
come countries [1]. Common mental disorders such as
depression and anxiety are frequently comorbid with
other health and psychosocial problems and are among
the most important causes of morbidity [1-3]. Mental
health remains a low priority in most low and middle
income countries and unmet needs for treatment are
pervasive [4-6].* Correspondence: g.armstrong@unimelb.edu.au
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distribution, and reproduction in any mediumMental disorders constitute a major public health
problem in India [7-9]. Epidemiological studies have
reported prevalence rates for psychiatric disorders vary-
ing from 9.5 to 370/1000 population, with prevalence
highest among marginalised populations and those most
disadvantaged by the phenomenon of rapid economic
growth and urbanization, such as urban slum dwellers
[10]. High rates of suicide have been documented in
India [11-14]. The real frequency of attempted suicide is
thought to be under-reported due to a poor reporting
system and the social taboos and legal ramifications
(attempted suicide is a punishable offence under Section
309 of the Indian Penal Code) connected to suicide
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of mental disorders and illicit substance use [16,17]. The
association can be explained in different ways. Psychi-
atric disturbance can occur before or after the com-
mencement of illicit substance use: people may use illicit
substances to manage their psychiatric symptoms; the
pharmacological properties of illicit substances such as
amphetamines can induce psychiatric symptoms; the
symptoms of withdrawal connected with drug addiction
can mimic those of common mental disorders; and, the
psychosocial stressors connected with life for people
who use illicit substances create distress and can have a
detrimental effect on mental health [18]. The precise ori-
gin of psychiatric symptoms may not be so critical given
that comorbid psychiatric symptoms in substance users
are connected with a poor long-term prognosis regard-
less of whether these symptoms were independent of the
substance use or were a consequence of it [19-21].
A high prevalence of symptoms of depression, anxiety
and suicidal ideation has been found among people who
inject drugs (PWID) in high-income country settings using
different diagnostic methods, instruments, cut-off values,
and population samples [22-26]. Few studies have exam-
ined the phenomenon of symptoms of common mental
disorders among PWID in Asian country settings, and
those few studies that have been undertaken have found
similarly high levels of psychiatric symptomatology [27-30].
To the best of our knowledge, there has been only one
community-based study among PWID in India that mea-
sured the prevalence of suicidal ideation and that was in
the context of a study focused on human rights violations
[31]; there have been no studies using community-based
samples that measured depression or anxiety symptoms.
This paper reports on the results of a cross-sectional
survey examining quality of life, depression and anxiety
symptoms, and suicidal ideation among a community-
based sample of adult males who inject drugs living in
Delhi. The populations of PWID in Delhi, estimated to
be at around 35,000 [32] are from various walks of life,
but most are substantially alienated and impoverished
and live at the margins of society [33]. Our study of
symptoms of common mental health problems among
PWID in Delhi will have implications for public health
programmes targeting this population.
The research questions framing our study were: (1) what
are the quality of life and socio-economic characteristics
of this population of PWID?; (2) what is the prevalence of
symptoms of depression and anxiety and suicidal idea-
tion?; (3) what psychosocial factors are associated with
symptoms of depression, anxiety and suicidal ideation?;
and, (4) is there an association between risky injecting and
sexual practices and symptoms of depression, anxiety and
suicidal ideation? This paper will only report on the first
and second research questions to allow for a fulldiscussion of the characteristics of this population. The
other objectives will be reported in depth elsewhere.
Methods
Study design
In April and May of 2012, a cross-sectional survey was
undertaken among PWID in Delhi using a structured
questionnaire that was interviewer-administered. Ethics
approval was provided in Australia by the Human Re-
search Ethics Committee at The University of Melbourne
(HREC 1137025). Local ethics approval was provided in
India by the Institutional Review Board (IRB) at Sharan,
The Society for Service to Urban Poverty. Sharan is an
NGO that provides services to injecting drug users in
New Delhi and is the partner NGO on this study.
Participants
Eligible participants were those who were 18 years of
age or older, had injected drugs at least once in the past
month, were not currently enrolled in opioid substitu-
tion therapy (i.e. buprenorphine), and had given their
informed oral consent to participate in the study. A con-
sent form and plain language statement were orally
communicated to potential participants, as literacy was
limited for many participants. Consent was obtained or-
ally after reading out the consent form. Participation in
the study was voluntary and anonymous – no names or
individually identifying information were recorded at any
stage. Participants were provided with a small meal (e.g.
chai and samosa) for their time in participating in the
study. Participants were free to withdraw from the study
during the questionnaire without losing access to the meal.
Participants were sampled from three needle and syr-
inge programmes (NSPs) in Delhi, each located in a dis-
tinctly different geographical area so that the sample was
drawn from a diverse range of PWID from across Delhi;
1) Yamuna Bazar, 2) Nabi Karim, and 3) Jahangirpuri.
Yamuna Bazar is located on the bank of the Yamuna
River in central Delhi and is the base for a large propor-
tion of the capital’s homeless and PWID. Jahangirpuri is
a slum resettlement colony on the outskirts of metropol-
itan Delhi. The NSP at Nabi Karim is located in an
urban ghetto in the Muslim quarter adjacent to New
Delhi Railway Station.
According to current data presented in the recent
National AIDS Control Organisation (NACO) Annual
Report 2011–2012 [34], it is estimated that 80% of the
officially mapped IDU population usually obtain their
needles from NSP targeted interventions depending on
the location.
Sampling method
The data were collected using Time Location Sampling
(TLS), a recognized method for obtaining a probability-
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sampling involves building a sampling frame from a list
of location and time combinations based upon the loca-
tions and times where you would expect to find mem-
bers of the target population. The NSPs were mapped in
terms of their operating hours and a list was constructed
based on a combination of the locations (i.e. NSPs) and
blocks of time (e.g. 3 hour blocks) during which the
NSP would be operating. Combinations of location and
time, known as sampling events, were then randomly se-
lected from the list to populate a sampling calendar. The
random number generator in Excel was used to randomly
select sampling events for each date on the sampling cal-
endar. The sampling calendar detailed the location and
time that the data collection team would attend on a given
date. Sampling was conducted during April and May 2012
until the desired sample size was achieved.
Based on programme data, it was anticipated that
there were twice as many PWID using the NSP in the
Yamuna Bazar location in comparison to the other two
locations. The selection of sampling events for the sam-
pling calendar was weighted with probability proportion-
ate to size, so that approximately half the sampling
events would be drawn from the Yamuna Bazar location
and the remaining half would be evenly split between
Jehangipuri and Nabi Karim.
The data collection team consisted of one field super-
visor, one enumerator and four interviewers who were
responsible for recruiting and interviewing participants.
During sampling events, the enumerator would use a
“counter” to count every male who used the NSP to ob-
tain new needles/syringes. Interviewers were directed by
the enumerator to approach potential participants im-
mediately after they had obtained new needles / syringes
from the NSP. Not all people using the NSP during a
sampling event could be approached to participate given
there was a limited number of interviewers. Additionally,
there would be more people attending the NSPs during
some sampling events than others, thus creating a sce-
nario of unequal probability of selection for participants
across sampling events. The enumerator counted all
people actually interviewed during each sampling event
in addition to counting those who had used the NSP to
enable the construction of selection probability weights
as discussed in the data analysis section below. Addition-
ally, the enumerator collected data on the number of
people who were approached yet declined to participate
and the number of participants who terminated the
interview early.
Data collection and measurement
The questionnaire was interviewer-administered to
maximize the quality of the data collected. The ques-
tionnaire had five domains: 1) background informationincluding socio-demographics, 2) drug use practices, 3)
sexual behaviour, 4) quality of life, and 5) symptoms of
depression, anxiety and suicidal ideation. It was antici-
pated that many of the participants would have never re-
ceived any schooling. As a result, the questionnaire was
kept as brief and simple as possible and it took approxi-
mately 30 minutes to complete. The questionnaire was
translated into Hindi, back-translated into English and
then piloted in the field to ensure equivalence and ap-
propriateness of the questions and scales. Local research
assistants were used for the data collection phase, all of
whom had previously been involved in administering
questionnaires with PWID. The research assistants were
trained in using the questionnaire and ethical research
conduct and were closely supervised by an experienced
local research officer.
Demographics, injecting and sexual practices
Questions regarding demographics, drug use and sexual
behaviours (predominantly condom use with various
partners) were adapted from previous research [39]
among injecting drug users in New Delhi and from a
sub-set of questions adapted from the Integrated Bio-
logical and Behavioural Assessment (IBBA) survey previ-
ously undertaken among injecting drug users in three
states of India, in both 2006 and 2009 [40].
Quality of life
Four generic questions relating to quality of life were
asked, covering four different aspects of quality of life.
The questions were adapted from themes contained
within the WHOQoL scale [41] and the IDUQoL scale
[42,43], neither of which proved feasible to use in this
study during pilot testing due to the length of these in-
struments and challenges in translating concepts. The
adapted questions were pertaining to: 1) hope for the
future, 2) feeling safe in daily life (i.e. from crime and
violence), 3) perception of health, and 4) relationship
with family. Additional socio-economic variables that
are also indicators of quality of life included: literacy,
level of education, income, source of income, housing,
history of imprisonment, experiences of being beaten
and inclusion in family events.
Symptoms of depression, anxiety and suicidal ideation
Symptoms of depression were measured using the Pa-
tient Health Questionnaire (PHQ-9), a nine-item screen-
ing tool based on criteria for depressive disorders in the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) [44,45]. The PHQ-9 has well established cri-
terion, construct and external validity [46,47]. The PHQ-
9 asks participants whether they have been bothered
with nine symptoms in the past two weeks, with re-
sponse options on a four-category Likert scale; not at all
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every day (3). The PHQ-9 is relatively short to administer
with scores ranging from 0 to 27. Scores of 5, 10, 15 and
20 represent thresholds marking the lower limits of mild,
moderate, moderately severe and severe depression.
The conventional cut-off is ≥10, yielding a sensitivity
of 88% and a specificity of 88% for major depression
[45]. The PHQ has previously been translated into
Hindi, validated for use among South Asian populations
and used in previous studies measuring the prevalence
of depressive symptoms among various communities in
India [48-52]. It has been recommended as a measure
for symptoms of depression among PWID in NSP
settings [53].
Symptoms of anxiety were measured using the Gener-
alised Anxiety Disorder (GAD-2) scale, a two-item ultra-
brief screening tool that follows the same format and
response options as the PHQ-9 [54]. Scores on the
GAD-2 range from 0 to 7 with a score of ≥3 re-
presenting the optimum cut-point for screening for anx-
iety disorders. The GAD-2 has high sensitivity (86%)
and specificity (83%) for detecting generalised anxiety
disorder and high specificity for panic disorder (81%),
social anxiety disorder (81%) and post-traumatic stress
disorder (81%) [54]. The GAD-2 has previously been
translated into Hindi.
Suicidal ideation was captured using three questions
adapted from the Suicide Behaviours Questionnaire
(SBQ) [55]. Questions were asked pertaining to: 1)
thoughts of suicide during the previous 12 months, 2)
the frequency of such thoughts, and 3) whether or not a
plan to act on these thoughts had been made. Addition-
ally, participants were asked whether they had attempted
suicide during the past 12 months.
Sample size
With an assumed prevalence of psychological distress of
50% (the most conservative assumption for the sample
size calculation) and a 95% confidence interval with a
5.5% margin of error, it was calculated that a sample size
of 312 PWID would be required. TLS sampling is similar
to cluster sampling, as randomly selected ‘blocks of time
and space’ are potentially clusters of homogeneity. The
required sample size was increased to 420 after adjusting
for a design effect of 1.25.
Data analysis
Data were entered into SPSS version 20 and cross-
checking was undertaken among 10% of questionnaires
to ensure there were no systematic errors when entering
the data. Preliminary tables were generated for each vari-
able to check for invalid entries. Data were analysed
using Stata version 10. Survey commands in Stata were
used to account for the TLS sampling design, specificallythe effect of clustering within sampling events and the
probability that a person was sampled [36,56]. Partici-
pants recruited at each sampling event (combination of
time and location) were treated as a cluster and standard
errors for variables were adjusted for intra-cluster cor-
relation. Sampling events at different times but at the
same location were treated as separate clusters. The
number of attendees at a sampling location during each
sampling event (i.e. enumeration count) was used as the
basis upon which to construct selection probability
weights. In brief, the first step was to calculate the pro-
portion that each event represented of the total enu-
meration count for the entire study. The second step
was to calculate the proportion of the total number of
interviews that each event represented for the entire
study. Finally, the result from step 1 was divided by the
result from step 2 to generate a weight that represents
the ratio of the number of persons enrolled into the
study relative to the number of persons available to
sample from at each sampling event. Thus, more weight
was given to participants recruited at highly-attended
sampling events.
Descriptive analysis produced adjusted proportions
and means with their respective 95% confidence inter-
vals (C.I.). The range and median were used to provide
important information as to the distribution of the
continuous depressive and anxiety symptom measures.
Because these statistics could not be generated using
survey commands in Stata, due to the limited options
available in these commands, they were generated with-
out adjustment for the sampling design.
Results
Recruitment
There were 420 PWID recruited into the study: 220
(52%) from Yamuna Bazar, 100 (24%) from Nabi Karim
and 100 (24%) from Jehangipuri. During recruitment
there were 173 PWID who were approached but de-
clined to participate; if we take a conservative assump-
tion that all 173 met the inclusion criteria, this would
indicate a response rate of 71% (420 ÷ (420 + 173)).
There were no occasions where a participant terminated
the interview before it was completed.
Demographics and substance use
Table 1 displays the demographic characteristics and sub-
stance use practices of PWID in this study setting. The
mean age was 36.7 (95% C.I. 35.5-37.9). Only one in nine
(11%) was below the age of 25 and one-quarter were aged
45 or older (26%). Many PWID were born outside of New
Delhi, with just over one-third (38%) being born there.
Just over half (53%) had never been married and nearly
one-quarter were either divorced / separated (16%) or
widowed (7%); more than half (60%) had no children.
Table 1 Demographics and substance use (n = 420)







New Delhi 38.3 (26.7-50.0)









Never married 53.3 (46.4-60.1)
Currently married 24.6 (17.8-31.4)




1–2 children 26.4 (22.0-30.9)
3–4 children 10.4 (6.3-14.5)
5+ 2.9 (0.6-5.2)
Current tobacco use
[smoking, chewing or in paan]
Daily 93.2 (90.1-96.2)
Less than daily 4.9 (2.3-7.6)
Not at all 1.9 (0.5-3.3)
Alcohol use – past month
Have never consumed alcohol 21.1 (14.4-27.7)
Not used in past month 43.4 (36.1-50.7)
Less than once a week 9.5 (6.9-12.1)
At least once a week 19.1 (14.4-23.7)
Everyday 7.0 (3.3-10.7)





Drugs used in the last 3 months a
Pheniramine maleate 99.0 (98.1-100.0)
Buprenorphine 97.4 (95.4-99.3)







Pentazocine / morphine 25.1 (19.6-30.6)
Other 22.2 (17.1-27.4)
Main drug injected in last 3 months b
Buprenorphine base 76.9 (69.7-84.1)
Heroin base 18.0 (11.6-24.3)
Other 5.2 (1.7-8.6)





a Buprenorphine, heroin, morphine, pentazocine (common brand name is
Fortwin) and Spasmoproxyvon are synthetic opioid analgesics.
Spasmoproxyvon is the brand name for a compound drug containing
dextropropoxyphene, dicyclomine hydrochloride and paracetamol.
Pheniramine maleate (common brand name is Avil) and promethazine
(common brand name is Phenergan) are antihistamines.
b Both buprenorphine and heroin are commonly injected in a cocktail
combination with a liquid antihistamine and often diazepam as well.
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PWID (93%). Few (7%) consumed alcohol daily. The
mean age of first injection was 15.8 (95% C.I. 15.3-16.3)
and one-third (34%) had first injected at the age of 13 or
younger. The mean length of injecting career was
20.9 years (95% C.I. 19.8-22.0). The most commonly used
opioids in the last three months were buprenorphine
(97%), heroin (77%), Spasmoproxyvon (27%) and pentazo-
cine / morphine (25%). Buprenorphine, Spasmoproxyvon
and pentazocine / morphine are synthetic opioid analge-
sics commonly found in chemist shops. Spasmoproxyvon
is the brand name for a compound drug containing
dextropropoxyphene, dicyclomine hydrochloride and
paracetamol. Other commonly used drugs were marijuana
(73%), diazepam (53%) and antihistamines (pheniramine
maleate / Avil 99%, promethazine / Phenergan 42%). The
main drug injected in the last three months was typically
buprenorphine (77%) or heroin (18%), both of which were
commonly injected in a cocktail with a liquid antihista-
mine and often diazepam as well. Few (14%) PWID were
injecting only once a day or less.
Quality of life and defining socio-economic characteristics
Table 2 presents the quality of life and socio-economic
characteristics, showing an extremely impoverished and
marginalised community of PWID. Just one-fifth of
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safe in their daily life from violence, crime and harass-
ment (18%); over one-quarter reported feeling not at all
safe (28%). Few rated their personal health as either very
good (1%) or good (11%). Similarly, few rated their
relationship to family as either very good (3%) or good
(14%) and the majority reported that they either rarely
(27%) or never (45%) attend family events.
The level of illiteracy was very high (62%) and just 2%
had completed 12 years of primary and secondary edu-
cation. On average, PWID in this community live off a
mean of 193.5 rupees per day (95% C.I. 181.1-206.0),
roughly $US3.50 and approximately half had a daily in-
come of ≤100 rupees (22%) or 101–150 rupees (27%).
Scavenging / rag picking was the main form of income
for 48% of PWID and just under one-third did either
unskilled manual work (19%) or skilled manual work
(11%). A small group of PWID primarily generated their
income from either crime (6%) or begging (2%).
There was a very high proportion of PWID who were
homeless (69%) and several others mostly slept in inse-
cure housing including rented rooms (6%) and other
temporary housing (4%). Seventy percent had a history
of imprisonment. Experiences of physical violence were
common: 33% had been beaten up at least twice during
the preceding six months and 11% had been beaten up
four or more times.
Depression, anxiety and suicidal ideation
Table 3 presents the prevalence of recent symptoms of
depression and anxiety and the 12-month prevalence of
suicidal ideation. The PHQ-9 scale had satisfactory in-
ternal consistency (Cronbach’s alpha coefficient = 0.73).
The mean PHQ-9 score was 14.7 out of a total possible
score of 27, with a range of 1 to 25 and a median of 15.
The prevalence of moderate or worse symptoms of de-
pression (cut-off ≥10) was 84% and the prevalence of
moderately severe to severe symptoms of depression
(cut-off ≥15) was 54%.
Among the nine items on the PHQ-9, the highest
average score was for the item “feeling bad about your-
self – or that you are a failure or have let yourself or
your family down”; the mean was 2.2 (95% C.I. 2.1-2.3).
The proportion of participants who received the max-
imum score of 3 (i.e. had this symptom nearly every day
in the last two weeks) for this item was 51% (95% C.I.
44%-58%).
The mean GAD-2 score was 3.4 out of a total pos-
sible score of 6, with a range of 0 to 6 and a median
of 4. Seventy-one percent qualified as having anxiety
symptomatology (cut-off score of ≥3). There was a
small group (10%, 95% C.I. 6%-14%) of PWID who
displayed no recent (i.e. past two weeks) symptoms of
either depression or anxiety.Suicidal ideation during the past 12 months was com-
mon. Fifty-three percent thought about killing them-
selves and almost one-quarter either often (15%) or very
often (7%) thought about killing themselves. A substan-
tial proportion reported to have actually attempted to
kill themselves (36%) in the past 12 months.Discussion
The findings from this study profile an impoverished,
vulnerable and isolated population of men who inject
drugs and whose lives are shaped by a significant level of
psychosocial distress. The average age of participants
was in the mid-30s with few aged below 25 and most
had commenced their injecting careers during adoles-
cence, indicative of a population of PWID who belong
to the more chronic end of the addiction spectrum. The
prevalence of symptoms of depression and anxiety was
very high and suicidal thoughts and acts were discon-
certingly common.Low quality of life and socio-economic status
More than half the participants were born outside of Delhi,
suggesting many of these men were part of the phe-
nomenon of large-scale migration into the city whether as
adults or children. Migration into Delhi has fuelled a popu-
lation growth rate of between 4-5% per year between 1951
and 2001 [57], making Delhi the home to 16.7 million
people [58] and a megacity that ranks among the largest
on the planet.
In our study, the quality of life and socio-economic in-
dicators reveal a socially excluded population of PWID
in Delhi who have minimal education and are often
homeless, leaving them vulnerable to physical violence,
poverty, poor health and imprisonment. These men are
clearly excluded from the rapid social and economic
progress around them.
The social exclusion extends to family relationships,
the core of the social fabric in India [59], with many
among this population never (45%) or rarely (27%) at-
tending family events. Aside from the potential for
breakdown in family relationships in connection with
migration, there are clearly other explanations connected
to drug addiction and family dynamics. The heightened
level of stigma, shame and alienation associated with
injecting drug use in a conservative Indian society would
threaten the integrity of a family and deepen the fractur-
ing of relationships [60]. To the best of our knowledge
there is minimal research in India, if any, examining
drug users’ perspectives regarding their relationships
with family and the potential for meaningful engagement
of family in drug treatment linked to harm reduction.
Given the pivotal role of family in Indian society, there
would be value in a more thorough examination of both
Table 2 Quality of life and socio-economic indicators
(n = 420)
Category % (95% C.I.)
Feel hopeful for your future
Very hopeful 21.1 (15.5-26.7)
Somewhat hopeful 60.0 (55.5-64.4)
Not at all hopeful 19.0 (14.4-23.5)
Feel safe in your daily life
[safe from violence, crime and harassment]
Very safe 17.7 (13.0-22.4)
Somewhat safe 54.2 (47.6-60.7)
Not at all safe 28.2 (21.8-34.6)
Rating of personal health




Very poor 15.6 (10.3-20.9)
Relationship with family




Very poor 19.2 (13.0-25.3)
Included in family events
Always 16.4 (9.6-23.2)






Years of primary and secondary
education completed
Never attended school 38.0 (32.7-43.3)
Completed between 1–4 years 28.0 (22.9-33.2)
Completed between 5–11 years 32.1 (27.4-36.8)
Completed 12 years 1.8 (0.6-3.1)
Daily income (rupees)a
≤100 rupees 21.9 (16.7-27.1)
101–150 rupees 26.8 (21.7-32.0)
151–200 rupees 24.3 (19.8-28.8)
201–250 rupees 11.9 (7.8-16.0)
251+ rupees 15.1 (10.7-19.6)
Main source of income
Skilled manual work 10.9 (6.3-15.5)
Unskilled manual work 18.7 (11.7-25.8)
Table 2 Quality of life and socio-economic indicators
(n = 420) (Continued)
Scavenging (e.g. rag picking) 47.8 (37.5-58.2)
Trading / vending 1.8 (0.5-3.2)
Crime (e.g. pick pocketing, selling drugs, etc.) 5.7 (2.4-9.0)
Begging 1.7 (0.1-3.3)
No source of income 11.1 (7.1-15.1)
Other 2.2 (0.1-3.9)
Place where slept most in past 3 months
Homeless 68.8 (57.4-80.3)
House / flat of relative or friend 16.0 (8.6-23.4)
Own house or flat 5.9 (1.6-10.2)
Rented room (hotel or rooming house) 5.7 (3.1-8.2)










a 1.00 USD = 54.25 rupees [as of 9th May 2013].
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drug dependence and family relationships.
A high prevalence of common mental health symptoms
There was a high prevalence of symptoms of depression
and anxiety among this community-based population of
men who inject drugs. In our study, 84% (PHQ-9 ≥10)
had symptoms of depression, 54% (PHQ-9 ≥15) had
moderately severe or severe symptoms of depression and
71% (GAD-2 ≥3) had symptoms of anxiety. The most
common symptom of depression was feelings of worth-
lessness and self-blame which is not very surprising
given the highly stigmatised nature of injecting drug
use, the disconnection with family and the deprived
socio-economic circumstances for many among this
population, but is in contrast to the findings of a
population-based survey of depression in Chennai that
also used the PHQ and reported depressed mood as the
most common symptom [51].
These results are somewhat comparable to studies
conducted in high-income countries among PWIDs
using self-report symptoms scales, despite variation in
study settings and the particular scale used. Lemstra
et al. [22] used the CES-D (cut-offs ≥16, ≥23) among
Table 3 Prevalence of recent symptoms of depression
and anxiety, and 12-month prevalence of suicidal
ideation (n = 420)
Category
Depression and anxiety scales - averages Mean (95% C.I.)
PHQ-9 score: average 14.66 (13.68-5.65)
GAD-2 score: average 3.44 (3.20-3.68)
Depression and anxiety scales – cut points % (95% C.I.)
PHQ-9 score: ≥10 84.4 (79.6-89.2)
PHQ-9 score: ≥15 54.2 (45.4-63.0)
PHQ-9 score: ≥20 17.4 (10.7-24.1)
GAD-2 score: ≥3 70.5 (64.3-76.8)
Suicidal ideation % (95% C.I.)
Have you thought about killing yourself in
the past 12 months?
No 46.9 (41.9-52.0)
Yes 53.1 (48.0-58.1)
How often have you thought about killing
yourself in the past 12 months?
Never 46.9 (41.9-52.0)
Rarely (1 time) 8.8 (5.4-12.2)
Sometimes (2 times) 22.1 (18.1-26.1)
Often (3–4 times) 15.1 (11.0-19.3)
Very often (5 or more times) 7.0 (4.2-9.9)
Have you ever made a plan to kill yourself in
the past 12 months?
No 66.3 (61.4-71.2)
Yes 33.7 (28.8-38.6)
Have you ever attempted to kill yourself in
the past 12 months?
No 63.8 (58.6-68.9)
Yes 36.3 (31.1-41.4)
Note: PHQ-9 scores of ≥10, ≥15 and ≥20 represent cut points for moderate,
moderately severe and severe depression symptomology. A GAD-2 score of ≥3
represents the optimum cut point when screening for anxiety.
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found a point prevalence of depressive symptomatology
of 81%, with 58% having more severe depressive symp-
toms. Perdue et al. [23] also used the CES-D (cut-off
≥23) among PWID in Seattle (USA) and similarly found
that 47% had more severe depressive symptoms. Brienza
et al. [24] used the Structured Clinical Interview for
DSM-III-R (SCID) and found a point prevalence of
major depression over the last 6 months of 54% among
PWID in Rhode Island (USA) attending needle syringe
exchange programmes and 42% among PWID attending
methadone maintenance treatment. Reyes et al. [25]
used the Beck Anxiety Inventory (moderate levels 16–
25, severe levels ≥26) among PWID in Puerto Rico; over
half of participants were found to have either moderate
(19%) or severe (37%) levels of anxiety.Similarly high prevalence rates have been found in
other studies conducted in the Asian region. Gu et al.
[28] used the Depression Anxiety and Stress Scale
(DASS) among a snowball sample of females who inject
drugs in Dazhou city (Sichuan Province, China) and
found a high percentage of participants reported depres-
sive symptoms (75% to 92%). Liao et al. [29] used the
Zung Self-Rating Anxiety Scale (SAS) and the Zung Self-
Rating Depression Scale (SDS) among a sample of
heroin-dependent patients in a treatment research clinic
in Changsha city (Hunan Province, China) and found a
high prevalence of both high anxiety (53%) and depres-
sion (43%) symptoms.
Our study revealed a disconcertingly high prevalence
of suicidal ideation. We found that 53% had thought
about killing themselves in the past 12 months and 34%
had made a plan to kill themselves. This result is the
same as that found by Sarin et al. [31] who measured
suicidal ideation among PWID in Delhi whilst conducting
a study focused on human rights abuses: 57% had thought
of taking their own life in the past six months and 42%
reported having made a specific plan about how they
would take their own life. High rates of suicidal ideation
have been found among PWID elsewhere: Havens et al.
[26] surveyed a sample of PWID in Maryland (USA) and
found that 27% had thought about killing themselves in
the past 6 months.
Our study also found that many (36%) men who inject
drugs in Delhi had moved beyond thinking about killing
themselves to actually attempting to kill themselves in
the past 12 months. Suicide is a real option for these
men, with at least one means readily available in the
form of a drug overdose. Chen et al. [30] also found that
suicide attempts were common among heroin users in
Taiwan; they surveyed entrants to methadone mainten-
ance treatment and found that 10.9% had attempted sui-
cide in the previous month.
Implications for programmes seeking to integrate a focus
on mental health
The high prevalence of psychological distress found in
this study has implications for programmes seeking to
engage, treat and rehabilitate PWID in India. Two broad
approaches appear to be worth further consideration, al-
though both face substantial challenges. One approach
to integrating mental health into services for PWID
would be to adopt a conventional psychiatric biomedical
model based around the use of screening tools and refer-
ral mechanisms complimented by the development of
mental health literacy [61,62] and mental health first aid
initiatives [63,64] for programmes providing services to
PWID. In an ideal world the development of locally ap-
propriate and easily administered and interpreted mental
health screening tools could provide a quick method for
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common mental health problems. Screening tools could
theoretically be complemented by the development of
pathways of referral for mental health assessment at the
primary health care level or, where appropriate, through
psychiatric institutions.
However, there is a question mark over whether con-
ventional screening and treatment approaches would be
effective for people who live in such adverse circum-
stances. Separating human distress from a diagnosis of
depression or anxiety is difficult [65]. Furthermore, given
that the unmet need for mental health care in India is
very high [4], it is unlikely that this disenfranchised
population group will be able to reliably access psychi-
atric or psychological treatment when needed without
strong advocacy and positive relationships with treat-
ment providers. The sheer number of new referrals that
may be generated from the regular use of screening tools
among this population group might overwhelm already
stretched mental health services. Additionally, there may
be obstacles to persuading PWID to attend assessments
and treatments and there may be financial barriers re-
lated to the costs of assessment and treatment.
Whilst severe depression and anxiety may require
psychiatric treatment, those with milder to moderate
symptoms could be better served by the adoption of a
broader public health approach that targets the popula-
tion rather than the individual [66]. The concept of
mental health promotion is a possible alternative to the
conventional psychiatric biomedical model. A mental
health promotion approach would involve addressing
the social determinants of mental health and well-being,
those being social inclusion, freedom from discrimin-
ation and violence and economic participation [67].
Structural interventions seeking to improve access to so-
cial/group activities and addressing unemployment and
housing insecurity could be critical strategies for ad-
dressing mental health among this population of men
who experience multiple levels of deprivation.
Limitations
The use of NSPs as the primary site of participant re-
cruitment may have created a sampling bias. Those
PWID who participated in this study are more likely to
be known to services and may represent the more
chronic end of the addiction spectrum. The method of
participant recruitment may have missed out on casual
users and those who were newer to injecting drug use.
Additionally, those who declined to participate may dif-
fer from those who did participate and we are unable to
assess the degree to which our participants were repre-
sentative of the broader NSP client group; however, a re-
sponse rate of 71% is acceptable and suggests the sample
is satisfactorily representative.Symptoms of depression and anxiety were measured
using self-report screening tools rather than a formal
psychiatric diagnosis. The selection of the optimal tool
for evaluating comorbid psychiatric conditions in drug
using populations remains controversial. In our study,
it is not possible to differentiate between psychiatric
symptoms that are independent of substance use and
those that were a consequence of it. Furthermore, the
high level of psychological distress among our study
participants is not surprising given their significant
socioeconomic stress, disconnection from family, and
the stigma connected to illicit drug addiction. Jacobs
[66] argues that symptom checklists, as used in this
study, take little regard of context, stress and coping,
and that separating human distress from depression is
difficult. The proportion of the participants who would
reach a formal diagnosis is unknown, and many may
be experiencing psychological distress related to their
socially adverse circumstances and may not reach
diagnostic criteria. Finally, we note that the use of a
comparison group in our study design and double-
entry at the point of data entry would have strength-
ened the methods.
Conclusions
Our study into men who inject drugs in Delhi revealed
an impoverished, vulnerable and isolated population
whose lives are shaped by a significant level of psycho-
social distress. The prevalence of depressive and anxiety
symptoms among this population of men who inject
drugs in Delhi was very high and suicidal thoughts and
acts were disconcertingly common. Given the above and
the high level of unmet need for mental health care in
India, further research and discussion is required to
inform the most appropriate public health response to
the mental health and wellbeing needs of this population
group.
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